180 Life Sciences Corp. Files 8-K: Material Agreement & Equity Sales
Ticker: FRMM · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financials
Related Tickers: ATNF
TL;DR
180 Life Sciences filed an 8-K on 4/6/25 for a material agreement and equity sales.
AI Summary
On April 6, 2025, 180 Life Sciences Corp. entered into a material definitive agreement. The company also reported unregistered sales of equity securities and filed financial statements and exhibits. The filing details are associated with accession number 0001213900-25-030101.
Why It Matters
This 8-K filing indicates significant corporate activity, including a new material agreement and the issuance of equity, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Numbers
- 20250406 — Report Date (Date of earliest event reported)
- 20250409 — Filing Date (Date the report was filed with the SEC)
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- April 6, 2025 (date) — Earliest event reported
- 0001213900-25-030101 (accession_number) — Filing accession number
- Delaware (jurisdiction) — State of incorporation
- 001-38105 (commission_file_number) — SEC file number
FAQ
What type of material definitive agreement did 180 Life Sciences Corp. enter into?
The filing states that 180 Life Sciences Corp. entered into a 'Material Definitive Agreement' but does not specify the nature of the agreement in the provided text.
What was the date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 6, 2025.
What is the SEC file number for 180 Life Sciences Corp.?
The SEC file number for 180 Life Sciences Corp. is 001-38105.
What are the main items reported in this 8-K filing?
This 8-K filing reports on the entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, and Financial Statements and Exhibits.
In which state is 180 Life Sciences Corp. incorporated?
180 Life Sciences Corp. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding 180 Life Sciences Corp. (FRMM).